Oral poliovirus vaccine in the United States: Molecular characterization of sabin type 3 after replication in the gut of vaccinees

MLA

Willard F. Waterfield, et al. “Oral Poliovirus Vaccine in the United States: Molecular Characterization of Sabin Type 3 after Replication in the Gut of Vaccinees.” Journal of Medical Virology, vol. 35, Oct. 1991, pp. 101–09. EBSCOhost, https://doi.org/10.1002/jmv.1890350206.

APA

Willard F. Waterfield, Thomas Davies, Carolyn Louise Weeks-Levy, Susan J. Dimichele, Bettina Sheip, Steven Joseph Mento, Mary B. Ritchey, Alice Georgiu, Francis R. Cano, Carmen Costalas, & J. M. Tatem. (1991). Oral poliovirus vaccine in the United States: Molecular characterization of sabin type 3 after replication in the gut of vaccinees. Journal of Medical Virology, 35, 101–109. https://doi.org/10.1002/jmv.1890350206

Chicago

Willard F. Waterfield, Thomas Davies, Carolyn Louise Weeks-Levy, Susan J. Dimichele, Bettina Sheip, Steven Joseph Mento, Mary B. Ritchey, et al. 1991. “Oral Poliovirus Vaccine in the United States: Molecular Characterization of Sabin Type 3 after Replication in the Gut of Vaccinees.” Journal of Medical Virology 35 (October): 101–9. doi:10.1002/jmv.1890350206.